DNA flow cytometry and morphometry as prognostic indicators in advanced ovarian cancer: A step forward in predicting the clinical outcome
- 1 February 1988
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 29 (2) , 176-187
- https://doi.org/10.1016/0090-8258(88)90212-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Tumor ploidy as a major prognostic factor in advanced ovarian cancerCancer, 1987
- DNA Flow Cytometry of Ovarian Tumors with Correlation to HistopathologyInternational Journal of Gynecological Pathology, 1985
- Application of DNA flow cytometry to paraffin‐embedded archival material for the study of aneuploidy and its clinical significanceCytometry, 1985
- Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin‐embedded tissueCytometry, 1985
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984
- Picogram per cell determination of DNA by flow cytofluorometryAnalytical Biochemistry, 1984
- Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.Journal of Histochemistry & Cytochemistry, 1983
- Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample‐storage, staining and internal standardizationCytometry, 1983
- The prognostic significance of morphometry in T1 bladder tumoursHistopathology, 1981
- Advanced ovarian cancer correlation of histologic grade with response to therapy and survivalCancer, 1980